These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 25547369)

  • 1. PEG-lipid micelles as drug carriers: physiochemical attributes, formulation principles and biological implication.
    Gill KK; Kaddoumi A; Nazzal S
    J Drug Target; 2015 Apr; 23(3):222-31. PubMed ID: 25547369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mixed micelles of lipoic acid-chitosan-poly(ethylene glycol) and distearoylphosphatidylethanolamine-poly(ethylene glycol) for tumor delivery.
    Elsaid Z; Taylor KM; Puri S; Eberlein CA; Al-Jamal K; Bai J; Klippstein R; Wang JT; Forbes B; Chana J; Somavarapu S
    Eur J Pharm Sci; 2017 Apr; 101():228-242. PubMed ID: 28163163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Micelles from lipid derivatives of water-soluble polymers as delivery systems for poorly soluble drugs.
    Lukyanov AN; Torchilin VP
    Adv Drug Deliv Rev; 2004 May; 56(9):1273-89. PubMed ID: 15109769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paclitaxel loaded PEG(5000)-DSPE micelles as pulmonary delivery platform: formulation characterization, tissue distribution, plasma pharmacokinetics, and toxicological evaluation.
    Gill KK; Nazzal S; Kaddoumi A
    Eur J Pharm Biopharm; 2011 Oct; 79(2):276-84. PubMed ID: 21575719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multifunctionality of lipid-core micelles for drug delivery and tumour targeting.
    Sawant RR; Torchilin VP
    Mol Membr Biol; 2010 Oct; 27(7):232-46. PubMed ID: 20929339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EGFR-targeted poly(ethylene glycol)-distearoylphosphatidylethanolamine micelle loaded with paclitaxel for laryngeal cancer: preparation, characterization and in vitro evaluation.
    Ren H; Gao C; Zhou L; Liu M; Xie C; Lu W
    Drug Deliv; 2015; 22(6):785-94. PubMed ID: 24670093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ascorbyl dipalmitate/PEG-lipid nanoparticles as a novel carrier for hydrophobic drugs.
    Moribe K; Maruyama S; Inoue Y; Suzuki T; Fukami T; Tomono K; Higashi K; Tozuka Y; Yamamoto K
    Int J Pharm; 2010 Mar; 387(1-2):236-43. PubMed ID: 20005934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro characterization of PEGylated phospholipid micelles for improved drug solubilization: effects of PEG chain length and PC incorporation.
    Ashok B; Arleth L; Hjelm RP; Rubinstein I; Onyüksel H
    J Pharm Sci; 2004 Oct; 93(10):2476-87. PubMed ID: 15349957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and characterization of polymeric micelles for solubilization of poorly soluble anticancer drugs.
    Sezgin Z; Yüksel N; Baykara T
    Eur J Pharm Biopharm; 2006 Nov; 64(3):261-8. PubMed ID: 16884896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of pluronic and PEG-PE micelles as carriers of meso-tetraphenyl porphine for oral administration.
    Sezgin Z; Yuksel N; Baykara T
    Int J Pharm; 2007 Mar; 332(1-2):161-7. PubMed ID: 17055200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Composition-dependent structural changes and antitumor activity of ASC-DP/DSPE-PEG nanoparticles.
    Higashi K; Mibu F; Saito K; Limwikrant W; Yamamoto K; Moribe K
    Eur J Pharm Sci; 2017 Mar; 99():24-31. PubMed ID: 27916697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymeric micelles: polyethylene glycol-phosphatidylethanolamine (PEG-PE)-based micelles as an example.
    Sawant RR; Torchilin VP
    Methods Mol Biol; 2010; 624():131-49. PubMed ID: 20217593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of poly(ethylene glycol)-distearoylphosphatidylethanolamine (PEG-DSPE) block copolymers and their derivatives as nanomaterials in drug delivery.
    Wang R; Xiao R; Zeng Z; Xu L; Wang J
    Int J Nanomedicine; 2012; 7():4185-98. PubMed ID: 22904628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and characterization of paclitaxel-loaded DSPE-PEG-liquid crystalline nanoparticles (LCNPs) for improved bioavailability.
    Zeng N; Hu Q; Liu Z; Gao X; Hu R; Song Q; Gu G; Xia H; Yao L; Pang Z; Jiang X; Chen J; Fang L
    Int J Pharm; 2012 Mar; 424(1-2):58-66. PubMed ID: 22240390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and evaluation of micellar nanocarriers for 17-allyamino-17-demethoxygeldanamycin (17-AAG).
    Chandran T; Katragadda U; Teng Q; Tan C
    Int J Pharm; 2010 Jun; 392(1-2):170-7. PubMed ID: 20363305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cholesterol on the release of amphotericin B from PEG-phospholipid micelles.
    Vakil R; Kwon GS
    Mol Pharm; 2008; 5(1):98-104. PubMed ID: 18159926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orthogonally functionalized nanoscale micelles for active targeted codelivery of methotrexate and mitomycin C with synergistic anticancer effect.
    Li Y; Lin J; Wu H; Chang Y; Yuan C; Liu C; Wang S; Hou Z; Dai L
    Mol Pharm; 2015 Mar; 12(3):769-82. PubMed ID: 25625539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solubilization of poorly soluble photosensitizer hypericin by polymeric micelles and polyethylene glycol.
    Búzová D; Kasák P; Miškovský P; Jancura D
    Gen Physiol Biophys; 2013 Jun; 32(2):201-8. PubMed ID: 23479449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiopep-2 modified PE-PEG based polymeric micelles for amphotericin B delivery targeted to the brain.
    Shao K; Huang R; Li J; Han L; Ye L; Lou J; Jiang C
    J Control Release; 2010 Oct; 147(1):118-26. PubMed ID: 20609375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DSPE-PEG: a distinctive component in drug delivery system.
    Che J; Okeke CI; Hu ZB; Xu J
    Curr Pharm Des; 2015; 21(12):1598-605. PubMed ID: 25594410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.